Topics

High BMI Linked to Better Immunotherapy Outcomes in NSCLC

12:20 EST 14 Feb 2020 | OncLive

A high body mass index at baseline may be independently associated with improved survival outcomes in patients with non–small cell lung cancer who receive immune checkpoint inhibitor therapy.

Original Article: High BMI Linked to Better Immunotherapy Outcomes in NSCLC

NEXT ARTICLE

More From BioPortfolio on "High BMI Linked to Better Immunotherapy Outcomes in NSCLC"

Quick Search

Relevant Topic

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...